Insights On Pharmaceutical Packaging
-
Blister Solutions
3/4/2025
With over 6,000 tooling parts and an in-house machining center to ensure precision, explore this versatile blister service that provides both Thermoformed and Cold-Formed solutions.
-
Meeting Annex 1: A Proactive Approach To Regulatory Compliance
3/4/2025
It was imperative for a large European CMO that produces multiple biologic drugs to select the right product quality and value for each customer to comply with the August 2023 revision to the EU GMP Annex 1.
-
Cold Chain Logistics And Packaging Considerations For Probiotics
7/5/2023
Choosing the right packaging partner for your probiotic may be the most crucial step to ensuring your product is safe and potent when it reaches the consumer.
-
Why Compounding Pharma Manufacturers Should Evaluate BFS Systems
12/5/2024
Discover how BFS technology offers compounding pharmacies and 503B facilities enhanced sterility, reduced errors, cost savings, and superior product integrity for aseptic pharmaceutical manufacturing.
-
Sachet Packaging Solutions
3/4/2025
Discover versatile, high-quality sachets for manufacturers and consumers with an ideal fill weight of 2 grams and above that is suitable for food or liquid formulas.
-
Choosing The Right Clinical Trial Packaging Partner: 5 Cs To Consider
10/9/2023
Today’s clinical studies demand flexible clinical trial services (CTS). Knowing what to look for when evaluating a CDMO can help avoid delays and ensure your product advances to market on schedule.
-
A Robust Extractables Data Package Helps Drive Patient Safety
10/1/2024
Complex drug product formulations are more common, so it is imperative to have a deeper knowledge of extractables to understand risks associated with potential interactions between packaging and product.
-
3D Screen Printing: Enabling A New Generation Of Complex Formulations
3/17/2025
Screen-Printed Innovative Drug Technology can produce oral, transdermal, and implantable dosage forms while ensuring heterogeneous distribution of active ingredients.
-
FAQs On The Revised EU GMP Annex 1: Volume 2
3/5/2025
Review the implementation of a holistic Contamination Control Strategy (CCS). Discover four key considerations for assessing component readiness: product, process, protection, and proof.
-
A Practical Packaging Components Checklist For Emerging Biotechs
6/20/2024
A proactive approach to packaging development can ultimately ensure a smoother launch. Explore five key considerations when selecting components for your injectable drug product.